-
Aug 9, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Researchers in Germany have developed a web-based tool, powered by machine learning, which extracts disease subtypes from large pools of patient data. The goal is more precise and robust predictions about molecular signatures that can serve as a starting point for investigating disease heterogeneity.
Full story
-
Aug 8, 2022, 10:15 AM
by
Cypex’s recombinant xenobiotic metabolizing enzymes complement BioIVT’s extensive portfolio of hepatocytes and related hepatic products for drug research and development.
Full story
-
Aug 8, 2022, 10:14 AM
by
The newly announced agenda for Connect in Pharma focuses on innovation as the foundation of a strong pharmaceutical industry in Europe. In order to ensure a strong future for European pharma, businesses need to prioritise digitalisation and maintain control of production lines, say two speakers due to present at the Geneva-based event in September.
Full story
-
Aug 5, 2022, 09:14 AM
by
Full story
-
Aug 5, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Though advancements in instruments and software have driven life sciences breakthroughs that drastically improve global health outcomes, researchers still struggle to maximize the value of the huge datasets that these high-throughput technologies generate. Currently, two common practices stand in the way of good data management at many life sciences institutions.
Full story
-
Aug 4, 2022, 09:37 AM
by
The charity Antibiotic Research UK welcomes Jonathan Pearce as the new CEO, effective 1 August 2022. He takes over the position from founder Professor Colin Garner, who retired at the end of July 2022.
Full story
-
Aug 4, 2022, 09:36 AM
by
Full story
-
Aug 3, 2022, 09:36 AM
by
BOC Sciences has been constantly enriching its peptide product library for years. Its peptides for diabetes research are recently brought into focus due to the growing concerns on this problem.
Full story
-
Aug 3, 2022, 09:35 AM
by
As an expert in chemistry, BOC Sciences understands how important the quality of phosphoramidite is to successful oligo synthesis and remarkably, it has taken concrete actions to manufacture certified products.
Full story
-
Aug 3, 2022, 09:34 AM
by
"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public.
Full story
-
Aug 3, 2022, 09:31 AM
by
Company focused on creating shot-free future of vaccines; first human trial of Vaxess MIMIX™ vaccine patch will focus on administering influenza vaccine
Full story
-
Aug 3, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Bio-IT World is bringing the Best of Show competition to Europe this fall at the Bio-IT World Conference & Expo Europe in Berlin, October 18-19.
Full story
-
Aug 2, 2022, 09:39 AM
by
Full story
-
Aug 2, 2022, 09:38 AM
by
Full story
-
Aug 2, 2022, 09:37 AM
by
Full story
-
Aug 2, 2022, 09:36 AM
by
Full story
-
Aug 2, 2022, 09:35 AM
by
Full story
-
Aug 2, 2022, 09:35 AM
by
Full story
-
Aug 2, 2022, 09:34 AM
by
Full story
-
Aug 2, 2022, 09:34 AM
by
GreenLight Biosciences and Samsung Biologics announce successful completion of the first commercial-scale engineering run for the companies' mRNA production partnership
Full story